Literature DB >> 20499165

Role of oxidative stress in the pathophysiology of bipolar disorder.

Amanda V Steckert1, Samira S Valvassori, Morgana Moretti, Felipe Dal-Pizzol, João Quevedo.   

Abstract

In this work, we review the studies of oxidative stress markers, showing association with the pathophysiology of bipolar disorder (BD). BD is a prevalent, chronic and highly disabling psychiatric disorder. Several hypotheses have been postulated to explain the exact neurochemical mechanisms underlying the pathophysiology of BD, including a role for monoamines, gamma-amino butyric acid (GABA), glutamate, and second messenger singling pathways. More recently, oxidative stress has been implicated in the pathogenesis of BD. Recent studies have reported increased products of lipid peroxidation and alterations of the major antioxidants enzymes in patients with BD. It has been widely demonstrated that the generation of reactive oxygen species (ROS) plays a critical role in the pathophysiology of several neuropsychiatric disorders, such BD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499165     DOI: 10.1007/s11064-010-0195-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  81 in total

1.  Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness.

Authors:  S Decker; G Grider; M Cobb; X P Li; M O Huff; R S El-Mallakh; R S Levy
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2000-04       Impact factor: 5.067

Review 2.  World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

Authors:  Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2005       Impact factor: 4.132

3.  Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

Authors:  J Cui; L Shao; L T Young; J-F Wang
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

4.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

Review 6.  Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.

Authors:  I Emerit
Journal:  Free Radic Biol Med       Date:  1994-01       Impact factor: 7.376

7.  The risk for cancer among patients with schizoaffective disorders.

Authors:  Itzhak Levav; Robert Kohn; Micha Barchana; Irena Lipshitz; Inna Pugachova; Abraham Weizman; Alexander Grinshpoon
Journal:  J Affect Disord       Date:  2009-04       Impact factor: 4.839

8.  Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells.

Authors:  Adedolapo Bakare; Li Shao; Jie Cui; L Trevor Young; Jun-Feng Wang
Journal:  Neurosci Lett       Date:  2009-03-11       Impact factor: 3.046

9.  Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

Authors:  Goro Fukami; Kenji Hashimoto; Kaori Koike; Naoe Okamura; Eiji Shimizu; Masaomi Iyo
Journal:  Brain Res       Date:  2004-07-30       Impact factor: 3.252

10.  Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

Authors:  Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

View more
  29 in total

Review 1.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

2.  Physical Exercise for Treatment of Mood Disorders: A Critical Review.

Authors:  C M Hearing; W C Chang; K L Szuhany; T Deckersbach; A A Nierenberg; L G Sylvia
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

Review 3.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice.

Authors:  Morgana Moretti; Josiane Budni; Danubia Bonfanti Dos Santos; Alessandra Antunes; Juliana Felipe Daufenbach; Luana Meller Manosso; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  J Mol Neurosci       Date:  2012-10-03       Impact factor: 3.444

5.  Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.

Authors:  Camila S Model; Lara M Gomes; Giselli Scaini; Gabriela K Ferreira; Cinara L Gonçalves; Gislaine T Rezin; Amanda V Steckert; Samira S Valvassori; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-01-03       Impact factor: 3.584

6.  The Neurobiology of Bipolar Disorder.

Authors:  Allan H Young; Mario F Juruena
Journal:  Curr Top Behav Neurosci       Date:  2021

7.  The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.

Authors:  Feng Liu; Jennifer Havens; Qi Yu; Gang Wang; Robin L Davisson; Virginia M Pickel; Costantino Iadecola
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-02-15

Review 8.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  Vitamin A and amygdala: functional and morphological consequences.

Authors:  Lenka Tomášová; Natália Hvizdošová; Adriana Boleková; Beňadik Smajda; Darina Kluchová
Journal:  Neurol Sci       Date:  2014-04-29       Impact factor: 3.307

10.  Altitude is a risk factor for completed suicide in bipolar disorder.

Authors:  Rebekah S Huber; Hilary Coon; Namkug Kim; Perry F Renshaw; Douglas G Kondo
Journal:  Med Hypotheses       Date:  2014-01-20       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.